세계의 희귀질환 진단 시장 : 점유율, 규모, 동향, 산업 분석 보고서 - 질병 유형별, 제품 유형별, 샘플 유형별, 기술별, 테스트별, 연령층별, 특성 유형별, 최종 사용자별, 지역별 부문 예측(2024-2032년)

The global rare disease diagnostics market size is expected to reach USD 88,969.27 million by 2032, according to a new study by Polaris Market Research. The report "Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rare disease diagnostics market is experiencing robust growth, driven by innovation is the increasing accessibility and affordability of genomic sequencing, facilitated by rapid technological advancements and economies of scale. As the cost of sequencing continues to decline and the speed of analysis improves, genomic testing has become more widely available, enabling healthcare providers to offer comprehensive genetic evaluations to patients with suspected rare diseases.

However, this involves the discovery and validation of novel testing methods, biomarkers, and technologies tailored for identifying rare diseases. Investments in R&D drive innovation, enabling the development of more accurate, efficient, and cost-effective testing solutions. Collaboration between academia, pharmaceutical companies, and biotech firms is crucial in advancing scientific understanding and translating discoveries into practical diagnostic tools.

The limited market size for treatments and diagnostic tools targeting rare diseases also contributes to their high cost. Advocacy organizations, policymakers, and healthcare stakeholders are working to raise awareness of the economic burden of rare diseases and implement measures to improve access to affordable diagnostic testing and treatments for affected individuals. Additionally, advancements in technology and collaborative research initiatives hold promise for driving down costs and improving the efficiency of rare disease diagnosis in the future.

Global Rare Disease Diagnostics Market Report Highlights

The Hematology and Oncology disease segment dominated the market owing to the precise and prompt detection of rare blood and oncological conditions, which led to early intervention and tailored treatment approaches.

The Kits and Reagents segment dominated and is anticipated to grow at the fastest CAGR owing to advancements in the detection of rare diseases, which enable quicker and more precise diagnosis.

The Research Laboratories and Cros segment dominated the market owing to cutting-edge infrastructure, advanced technologies, and skilled personnel for diagnostic purposes.

The Diagnostics Laboratories segment is expected to witness the highest CAGR over the anticipated period due to a rise in demand for specialized diagnostic services that can accurately identify and diagnose rare diseases.

North America led the industry and accounted for a majority of market revenue share owing to the progress made in genetic testing and precision medicine, which play crucial roles in diagnosing and treating rare conditions.

The global key market players include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., FDNA(TM) INC, GeneDx, LLC, Illumina, Inc., Invitae Corporation, Novo Nordisk A/S, Quest Diagnostics, etc.

Polaris Market Research has segmented the global rare disease diagnostics market report based on disease type, product type, sample type, technology, test, age group, trait type, end-user, and region:

Global Rare Disease Diagnostics, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

• Gastroenterology Disease
• Endocrine and Metabolism Disorders Disease
• Cardiovascular Disorders
• Musculoskeletal Disorders
• Neurology Disease
• Hematology and Oncology Disease
• Dermatology Disease
• Others

Global Rare Disease Diagnostics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

• Kits & Reagents
• Instruments
• Software

Global Rare Disease Diagnostics, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

• Blood Sample
• Buccal Swab Sample
• Others

Global Rare Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

• Next Generation Sequencing
• Whole Exome
• Whole Genome
• Array Technology
• PCR Based Testing
• FISH
• Sanger Sequencing
• Karyotyping

Global Rare Disease Diagnostics, Test Outlook (Revenue - USD Million, 2019 - 2032)

• Genetic Test
• General Lab Test
• Imaging Test

Global Rare Disease Diagnostics, Age Group Outlook (Revenue - USD Million, 2019 - 2032)

• Children
• Adult

Global Rare Disease Diagnostics, Trait Type Outlook (Revenue - USD Million, 2019 - 2032)

• Inherited
• Acquired

Global Rare Disease Diagnostics, End- Use Outlook (Revenue - USD Million, 2019 - 2032)

• Research Laboratories & Cros
• Hospitals & Clinics
• Diagnostic Laboratories

Global Rare Disease Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Australia
• Malaysia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions

2. Stakeholders

3. Executive Summary

• 3.1. Market Highlights

4. Research Methodology

• 4.1. Overview
  • 4.1.1. Data Mining
• 4.2. Data Sources
  • 4.2.1. Primary Sources
  • 4.2.2. Secondary Sources

5. Global Rare Disease Diagnostics Market Insights

• 5.1. Rare Disease Diagnostics - Industry Snapshot
• 5.2. Rare Disease Diagnostics Market Dynamics
  • 5.2.1. Drivers and Opportunities
    • 5.2.1.1. Advances in genomic technologies drive diagnostic innovation
    • 5.2.1.2. Increasing awareness leads to higher demand for diagnostics
  • 5.2.2. Restraints and Challenges
    • 5.2.2.1. High costs
  • 5.2.3. Porter's Five Forces Analysis
    • 5.2.3.1. Bargaining Power of Suppliers (Moderate)
    • 5.2.3.2. Threats of New Entrants (Low)
    • 5.2.3.3. Bargaining Power of Buyers (Moderate)
    • 5.2.3.4. Threat of Substitute (Moderate)
    • 5.2.3.5. Rivalry among Existing Firms (High)
• 5.3. PESTEL Analysis
• 5.4. Rare Disease Diagnostics Industry
• 5.5. Value Chain Analysis
• 5.6. COVID-19 Impact Analysis

6. Global Rare Disease Diagnostics Market, by Disease Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
• 6.3. Gastroenterology Disease
  • 6.3.1. Global Rare Disease Diagnostics Market, by Gastroenterology Disease, by Region, 2019-2032 (USD Million)
• 6.4. Endocrine and Metabolism Disorders Disease
  • 6.4.1. Global Rare Disease Diagnostics Market, by Endocrine and Metabolism Disorders Disease, by Region, 2019-2032 (USD Million)
• 6.5. Cardiovascular Disorders
  • 6.5.1. Global Rare Disease Diagnostics Market, by Cardiovascular Disorders, by Region, 2019-2032 (USD Million)
• 6.6. Musculoskeletal Disorders
  • 6.6.1. Global Rare Disease Diagnostics Market, by Musculoskeletal Disorders, by Region, 2019-2032 (USD Million)
• 6.7. Neurology Disease
  • 6.7.1. Global Rare Disease Diagnostics Market, by Neurology Disease, by Region, 2019-2032 (USD Million)
• 6.8. Hematology and Oncology Disease
  • 6.8.1. Global Rare Disease Diagnostics Market, by Hematology and Oncology Disease, by Region, 2019-2032 (USD Million)
• 6.9. Dermatology Disease
  • 6.9.1. Global Rare Disease Diagnostics Market, by Dermatology Disease, by Region, 2019-2032 (USD Million)
• 6.10. Others
  • 6.10.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Rare Disease Diagnostics Market, by Mode of Product Type

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
• 7.3. Kits & Reagents
  • 7.3.1. Global Rare Disease Diagnostics Market, by Kits & Reagents, by Region, 2019-2032 (USD Million)
• 7.4. Instruments
  • 7.4.1. Global Rare Disease Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
• 7.5. Software
  • 7.5.1. Global Rare Disease Diagnostics Market, by Software, by Region, 2019-2032 (USD Million)

8. Global Rare Disease Diagnostics Market, by Sample Type

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
• 8.3. Blood Sample
  • 8.3.1. Global Rare Disease Diagnostics Market, by Blood Sample, by Region, 2019-2032 (USD Million)
• 8.4. Buccal Swab Sample
  • 8.4.1. Global Rare Disease Diagnostics Market, by Buccal Swab Sample, by Region, 2019-2032 (USD Million)
• 8.5. Others
  • 8.5.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Rare Disease Diagnostics Market, by Technology

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
• 9.3. Next Generation Sequencing
  • 9.3.1. Global Rare Disease Diagnostics Market, by Next Generation Sequencing, by Region, 2019-2032 (USD Million)
• 9.4. Whole Exome
  • 9.4.1. Global Rare Disease Diagnostics Market, by Whole Exome, by Region, 2019-2032 (USD Million)
• 9.5. Whole Genome
  • 9.5.1. Global Rare Disease Diagnostics Market, by Whole Genome, by Region, 2019-2032 (USD Million)
• 9.6. Array Technology
  • 9.6.1. Global Rare Disease Diagnostics Market, by Array Technology, by Region, 2019-2032 (USD Million)
• 9.7. PCR Based Testing
  • 9.7.1. Global Rare Disease Diagnostics Market, by PCR Based Testing, by Region, 2019-2032 (USD Million)
• 9.8. FISH
  • 9.8.1. Global Rare Disease Diagnostics Market, by FISH, by Region, 2019-2032 (USD Million)
• 9.9. Sanger Sequencing
  • 9.9.1. Global Rare Disease Diagnostics Market, by Sanger Sequencing, by Region, 2019-2032 (USD Million)
• 9.10. Karyotyping
  • 9.10.1. Global Rare Disease Diagnostics Market, by Karyotyping, by Region, 2019-2032 (USD Million)

10. Global Rare Disease Diagnostics Market, by Test

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Global Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
• 10.3. Genetic Test
  • 10.3.1. Global Rare Disease Diagnostics Market, by Genetic Test, by Region, 2019-2032 (USD Million)
• 10.4. General Lab Test
  • 10.4.1. Global Rare Disease Diagnostics Market, by General Lab Test, by Region, 2019-2032 (USD Million)
• 10.5. Imaging Test
  • 10.5.1. Global Rare Disease Diagnostics Market, by Imaging Test, by Region, 2019-2032 (USD Million)

11. Global Rare Disease Diagnostics Market, by Age Group

• 11.1. Key Findings
• 11.2. Introduction
  • 11.2.1. Global Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
• 11.3. Adult
  • 11.3.1. Global Rare Disease Diagnostics Market, by Adult, by Region, 2019-2032 (USD Million)
• 11.4. Children
  • 11.4.1. Global Rare Disease Diagnostics Market, by Children, by Region, 2019-2032 (USD Million)

12. Global Rare Disease Diagnostics Market, by Trait Type

• 12.1. Key Findings
• 12.2. Introduction
  • 12.2.1. Global Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
• 12.3. Inherited
  • 12.3.1. Global Rare Disease Diagnostics Market, by Inherited, by Region, 2019-2032 (USD Million)
• 12.4. Acquired
  • 12.4.1. Global Rare Disease Diagnostics Market, by Acquired, by Region, 2019-2032 (USD Million)

13. Global Rare Disease Diagnostics Market, by End-Use

• 13.1. Key Findings
• 13.2. Introduction
  • 13.2.1. Global Rare Disease Diagnostics Market, by End-Use, 2019-2032 (USD Million)
• 13.3. Research Laboratories & CROs
  • 13.3.1. Global Rare Disease Diagnostics Market, by Research Laboratories & CROs, by Region, 2019-2032 (USD Million)
• 13.4. Hospitals & Clinics
  • 13.4.1. Global Rare Disease Diagnostics Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Million)
• 13.5. Diagnostic Laboratories
  • 13.5.1. Global Rare Disease Diagnostics Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)

14. Global Rare Disease Diagnostics Market, by Geography

• 14.1. Key Findings
• 14.2. Introduction
  • 14.2.1. Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
• 14.3. Rare Disease Diagnostics Market - North America
  • 14.3.1. North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 14.3.2. North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 14.3.3. North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 14.3.4. North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 14.3.5. North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 14.3.6. North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 14.3.7. North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.3.8. Rare Disease Diagnostics Market - U.S.
    • 14.3.8.1. U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.3.8.2. U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.3.8.3. U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.3.8.4. U.S.: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.3.8.5. U.S.: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.3.8.6. U.S.: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.3.8.7. U.S.: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.3.9. Rare Disease Diagnostics Market - Canada
    • 14.3.9.1. Canada: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.3.9.2. Canada: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.3.9.3. Canada: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.3.9.4. Canada: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.3.9.5. Canada: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.3.9.6. Canada: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.3.9.7. Canada: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
• 14.4. Rare Disease Diagnostics Market - Europe
  • 14.4.1. Europe: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 14.4.2. Europe: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 14.4.3. Europe: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 14.4.4. Europe: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 14.4.5. Europe: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 14.4.6. Europe: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 14.4.7. Europe: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.8. Rare Disease Diagnostics Market - UK
    • 14.4.8.1. UK: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.8.2. UK: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.8.3. UK: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.8.4. UK: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.8.5. UK: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.8.6. UK: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.8.7. UK: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.9. Rare Disease Diagnostics Market - France
    • 14.4.9.1. France: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.9.2. France: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.9.3. France: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.9.4. France: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.9.5. France: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.9.6. France: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.9.7. France: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.10. Rare Disease Diagnostics Market - Germany
    • 14.4.10.1. Germany: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.10.2. Germany: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.10.3. Germany: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.10.4. Germany: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.10.5. Germany: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.10.6. Germany: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.10.7. Germany: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.11. Rare Disease Diagnostics Market - Italy
    • 14.4.11.1. Italy: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.11.2. Italy: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.11.3. Italy: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.11.4. Italy: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.11.5. Italy: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.11.6. Italy: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.11.7. Italy: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.12. Rare Disease Diagnostics Market - Spain
    • 14.4.12.1. Spain: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.12.2. Spain: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.12.3. Spain: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.12.4. Spain: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.12.5. Spain: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.12.6. Spain: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.12.7. Spain: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.13. Rare Disease Diagnostics Market - Netherlands
    • 14.4.13.1. Netherlands: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.13.2. Netherlands: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.13.3. Netherlands: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.13.4. Netherlands: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.13.5. Netherlands: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.13.6. Netherlands: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.13.7. Netherlands: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4.14. Rare Disease Diagnostics Market - Russia
    • 14.4.14.1. Russia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.14.2. Russia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.14.3. Russia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.14.4. Russia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.14.5. Russia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.14.6. Russia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.14.7. Russia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
• 14.5. Rare Disease Diagnostics Market - Asia Pacific
  • 14.5.1. Asia Pacific: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 14.5.2. Asia Pacific: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 14.5.3. Asia Pacific: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 14.5.4. Asia Pacific: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 14.5.5. Asia Pacific: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 14.5.6. Asia Pacific: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 14.5.7. Asia Pacific: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.8. Rare Disease Diagnostics Market - China
    • 14.5.8.1. China: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.8.2. China: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.8.3. China: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.8.4. China: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.8.5. China: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.8.6. China: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.8.7. China: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.9. Rare Disease Diagnostics Market - India
    • 14.5.9.1. India: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.9.2. India: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.9.3. India: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.9.4. India: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.9.5. India: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.9.6. India: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.9.7. India: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.10. Rare Disease Diagnostics Market - Japan
    • 14.5.10.1. Japan: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.10.2. Japan: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.10.3. Japan: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.10.4. Japan: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.10.5. Japan: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.10.6. Japan: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.10.7. Japan: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.11. Rare Disease Diagnostics Market - Malaysia
    • 14.5.11.1. Malaysia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.11.2. Malaysia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.11.3. Malaysia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.11.4. Malaysia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.11.5. Malaysia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.11.6. Malaysia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.11.7. Malaysia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.12. Rare Disease Diagnostics Market - Indonesia
    • 14.5.12.1. Indonesia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.12.2. Indonesia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.12.3. Indonesia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.12.4. Indonesia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.12.5. Indonesia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.12.6. Indonesia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.12.7. Indonesia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5.13. Rare Disease Diagnostics Market - South Korea
    • 14.5.13.1. South Korea: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.13.2. South Korea: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.13.3. South Korea: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.13.4. South Korea: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.13.5. South Korea: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.13.6. South Korea: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.13.7. South Korea: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
• 14.6. Rare Disease Diagnostics Market - Middle East & Africa
  • 14.6.1. Middle East & Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 14.6.2. Middle East & Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 14.6.3. Middle East & Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 14.6.4. Middle East & Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 14.6.5. Middle East & Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 14.6.6. Middle East & Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 14.6.7. Middle East & Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6.8. Rare Disease Diagnostics Market - Saudi Arabia
    • 14.6.8.1. Saudi Arabia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.8.2. Saudi Arabia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.8.3. Saudi Arabia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.8.4. Saudi Arabia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.8.5. Saudi Arabia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.8.6. Saudi Arabia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.8.7. Saudi Arabia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6.9. Rare Disease Diagnostics Market - UAE
    • 14.6.9.1. UAE: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.9.2. UAE: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.9.3. UAE: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.9.4. UAE: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.9.5. UAE: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.9.6. UAE: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.9.7. UAE: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6.10. Rare Disease Diagnostics Market - Israel
    • 14.6.10.1. Israel: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.10.2. Israel: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.10.3. Israel: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.10.4. Israel: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.10.5. Israel: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.10.6. Israel: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.10.7. Israel: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6.11. Rare Disease Diagnostics Market - South Africa
    • 14.6.11.1. South Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.11.2. South Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.11.3. South Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.11.4. South Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.11.5. South Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.11.6. South Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.11.7. South Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
• 14.7. Rare Disease Diagnostics Market - Latin America
  • 14.7.1. Latin America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 14.7.2. Latin America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 14.7.3. Latin America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 14.7.4. Latin America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 14.7.5. Latin America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 14.7.6. Latin America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 14.7.7. Latin America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7.8. Rare Disease Diagnostics Market - Mexico
    • 14.7.8.1. Mexico: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.8.2. Mexico: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.8.3. Mexico: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.8.4. Mexico: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.8.5. Mexico: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.8.6. Mexico: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.8.7. Mexico: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7.9. Rare Disease Diagnostics Market - Brazil
    • 14.7.9.1. Brazil: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.9.2. Brazil: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.9.3. Brazil: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.9.4. Brazil: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.9.5. Brazil: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.9.6. Brazil: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.9.7. Brazil: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7.10. Rare Disease Diagnostics Market - Argentina
    • 14.7.10.1. Argentina: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.10.2. Argentina: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.10.3. Argentina: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.10.4. Argentina: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.10.5. Argentina: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.10.6. Argentina: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.10.7. Argentina: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)

15. Competitive Landscape

• 15.1. Expansion and Acquisition Analysis
  • 15.1.1. Expansion
  • 15.1.2. Acquisitions
• 15.2. Partnerships/Collaborations/Agreements/Exhibitions

16. Company Profiles

• 16.1. 3billion, Inc.
  • 16.1.1. Company Overview
  • 16.1.2. Financial Performance
  • 16.1.3. Product Benchmarking
  • 16.1.4. Recent Development
• 16.2. Agilent Technologies, Inc
  • 16.2.1. Company Overview
  • 16.2.2. Financial Performance
  • 16.2.3. Product Benchmarking
  • 16.2.4. Recent Development
• 16.3. CENTOGENE N.V
  • 16.3.1. Company Overview
  • 16.3.2. Financial Performance
  • 16.3.3. Product Benchmarking
  • 16.3.4. Recent Development
• 16.4. F. Hoffmann-La Roche Ltd
  • 16.4.1. Company Overview
  • 16.4.2. Financial Performance
  • 16.4.3. Product Benchmarking
  • 16.4.4. Recent Development
• 16.5. FDNA(TM) INC
  • 16.5.1. Company Overview
  • 16.5.2. Financial Performance
  • 16.5.3. Product Benchmarking
  • 16.5.4. Recent Development
• 16.6. GeneDx, LLC
  • 16.6.1. Company Overview
  • 16.6.2. Financial Performance
  • 16.6.3. Product Benchmarking
  • 16.6.4. Recent Development
• 16.7. Illumina, Inc.
  • 16.7.1. Company Overview
  • 16.7.2. Financial Performance
  • 16.7.3. Product Benchmarking
  • 16.7.4. Recent Development
• 16.8. Invitae Corporation
  • 16.8.1. Company Overview
  • 16.8.2. Financial Performance
  • 16.8.3. Product Benchmarking
  • 16.8.4. Recent Development
• 16.9. Novo Nordisk A/S
  • 16.9.1. Company Overview
  • 16.9.2. Financial Performance
  • 16.9.3. Product Benchmarking
  • 16.9.4. Recent Development
• 16.10. Quest Diagnostics
  • 16.10.1. Company Overview
  • 16.10.2. Financial Performance
  • 16.10.3. Product Benchmarking
  • 16.10.4. Recent Development